Literature DB >> 11509176

Dendritic cells as vectors for therapy.

J Banchereau1, B Schuler-Thurner, A K Palucka, G Schuler.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11509176     DOI： 10.1016/s0092-8674(01)00448-2

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  76 in total

1.  Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice.

Authors:  Yanli Ding; Chun-Shiang Chung; Sarah Newton; Yaping Chen; Stacey Carlton; Jorge E Albina; Alfred Ayala
Journal:  Shock       Date:  2004-08       Impact factor: 3.454

2.  Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Authors:  Rachel A Reboulet; Cassandra M Hennies; Zacarias Garcia; Stefan Nierkens; Edith M Janssen
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

3.  Spontaneous proliferation and type 2 cytokine secretion by CD4+T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells.

Authors:  A Karolina Palucka; John Connolly; Hideki Ueno; John Kohl; Sophie Paczesny; Madhav Dhodapkar; Joseph Fay; Jacques Banchereau
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

Review 4.  Intravenous immunoglobulin and dendritic cells.

Authors:  Namita Misra; Jagadeesh Bayry; Jagadeesh Bayary; Sooryasarathi Dasgupta; Amal Ephrem; Jean-Paul Duong Van Huyen; Sandrine Delignat; Gazzala Hassan; Giuseppina Caligiuri; Antonino Nicoletti; Sebastien Lacroix-Desmazes; Michel D Kazatchkine; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

5.  Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines.

Authors:  Ruijiang Song; Shuqin Liu; Kam W Leong
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

Review 6.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

Review 7.  Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments.

Authors:  Philip Wintermeyer; Jack R Wands
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

8.  T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.

Authors:  Madhav V Dhodapkar; Joseph Krasovsky; Kara Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

9.  Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.

Authors:  Sumia Ali; Gwendalyn D King; James F Curtin; Marianela Candolfi; Weidong Xiong; Chunyan Liu; Mariana Puntel; Queng Cheng; Jesus Prieto; Antoni Ribas; Jerzy Kupiec-Weglinski; Nico van Rooijen; Hans Lassmann; Pedro R Lowenstein; Maria G Castro
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

10.  Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.

Authors:  Anne Flörcken; Joachim Kopp; Antje van Lessen; Kamran Movassaghi; Anna Takvorian; Korinna Jöhrens; Markus Möbs; Constanze Schönemann; Birgit Sawitzki; Karl Egerer; Bernd Dörken; Antonio Pezzutto; Jörg Westermann
Journal:  Hum Vaccin Immunother       Date:  2013-03-04       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.